Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Annina Markhoff"'
Publikováno v:
Tissue Engineering Part C: Methods. 24:280-288
Tissue antigenicity represents the main limitation for the use of xenografts in clinical practice. To eliminate xenoantigens and avoid graft rejection in human, decellularization is often used to remove all immunoreactive components from the extracel
Autor:
Oliver Bloch, Aila Daugs, Beate Hutzler, Annina Markhoff, Lehmann Nadine, Martina C. Meinke, Schmitz Christoph
Publikováno v:
Annals of Biomedical Engineering. 45:2683-2692
Vascular diseases are an increasing health issue, and common alloplastic, allogenic or autologous vascular grafts show frequent complications. The aim of this study is to develop an acellular, xenogenic bypass-graft from a bovine carotid artery (BAC)
Autor:
Uwe Marx, Annina Markhoff, Gerd Lindner, Roland Lauster, Martin Blechert, Katharina Schimek, Frank Sonntag
Publikováno v:
BMC Proceedings
Background Tests for drug development require an almost perfect fit with the human (patho-) physiological microenvironment. The majority of skin equivalents currently commercially available are based on static culture systems emulating only human epi
Autor:
Daugs, Aila, Lehmann, Nadine, Eroglu, Dilem, Meinke, Martina C., Markhoff, Annina, Bloch, Oliver
Publikováno v:
Tissue Engineering Part C: Methods; May2018, Vol. 24 Issue 5, p280-288, 9p
Autor:
Daugs, Aila, Hutzler, Beate, Meinke, Martina, Schmitz, Christoph, Lehmann, Nadine, Markhoff, Annina, Bloch, Oliver
Publikováno v:
Annals of Biomedical Engineering; Nov2017, Vol. 45 Issue 11, p2683-2692, 10p